This site is intended for healthcare professionals only
LoginRegister
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJohnson and Johnson gets European Commission nod for expanded use of HIV 1 therapy Edurant in...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAIQVIA Gets CDSCO Panel Nod to Study KarXT in Schizophrenia
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSanofi gets CDSCO Panel nod to study Amlitelimab
CDSCO Panel Declines to Consider ACME Generics Phase IV Trial Results for Liothyronine TabletsLa Renon's plea to exempt Sodium Valproate from NPPA price cap rejected
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealAbbott initiates new clinical trial to improve outcomes in patients with advanced Heart Failure
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentMerck acquires cancer therapy developer Modifi Biosciences
Cipla Names Arun Kakatkar as Global Chief People OfficerDoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceFortis trademark to be auctioned: HC order
Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye DeviceMedtronic bags USFDA approval of Affera Mapping and Ablation System and Sphere-9 Catheter
Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017PM Modi inaugurates medical devices plant in Vapi
PM ModiPM Modi inaugurates Lyfius Pharma Penicillin-G Facility in AP
X